Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: Association with disease severity and delayed mycobacterial clearance with treatment
Date
2013
Authors
Ralph, Anna P
Yeo, Tsin W.
Salome, Cheryl
Waramori, G
Pontororing, Gysje J
Kenangalem, Enny
Sandjaja, .
Tjitra, Emiliana
Lumb, Richard
Maguire, Graeme P.
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Background. Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. We investigated relationships between fractional exhale NO (FENO) and
Description
Keywords
Keywords: arginine; nitric oxide; vitamin D; adolescent; adult; aged; article; bacterial clearance; controlled study; disease association; disease severity; female; follow up; forced vital capacity; human; lung tuberculosis; major clinical study; male; Papua New Gu Biomarker; Exhaled nitric oxide; L-arginine; M2 macrophages; Tuberculosis
Citation
Collections
Source
International Journal of Infectious diseases
Type
Journal article
Book Title
Entity type
Access Statement
License Rights
Restricted until
2037-12-31
Downloads
File
Description